Feb 11, 2019 - GSK collaborates with Merck KGaA on M7824, a TGF-beta.M7824 represents a class of agents considered to be the future of Immuno-Oncology.Late stage trials are needed to validate, M7824; if successful,
Feb 08, 2019 - The FDA extends the review period of Incyte's (INCY) sNDA for the label expansion of Jakafi for the treatment of acute GVHD.
Feb 08, 2019 - Seattle Genetics (SGEN) incurs wider-than-expected loss in Q4 but rides high on revenue beat.
Feb 08, 2019 - Merck (MRK) and Lilly (LLY) report Q4 results. CHMP gives nod to several drugs.
Feb 07, 2019 -
Feb 06, 2019 - Merck & Co Inc (MRK) Chairman, President & CEO Kenneth C Frazier Sold $18.1 million of Shares, Stocks: MRK, release date:Feb 06, 2019
Feb 06, 2019 -
Feb 05, 2019 - Merck (MRK) secures a positive verdict from the Committee for Medicinal Products for Human Use to approve Keytruda's combo therapy for first-line treatment of a difficult lung cancer population.
Feb 04, 2019 -
Feb 04, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it takes? Let's find out.